Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2013. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2013. Go to the latest filing (Q3 2026)

3.9B USDQ2 2013
Total value of stock positions
3.9B USD
Positions
22
Share of the ten largest
93.8%

The ten largest positions Q2 2013

  1. Viasat Inc 20.0%
  2. BP (ADR) 19.8%
  3. Theravance Inc 16.2%
  4. Micron Technology 15.1%
  5. American International Group 11.5%
  6. Rovi Corp 3.6%
  7. Idenix Pharmaceuticals Inc 2.5%
  8. Citigroup Inc 1.9%
  9. Oracle Corporation 1.9%
  10. Chipmos Tech Bermuda Ltd 1.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q2 2013

There is no filing for the previous quarter – changes cannot be shown for Q2 2013.

Positions Q2 2013 per 13F filing, 22 of 22
Symbol Weight Shares Reported value Change Held since
Viasat Inc 20.0% 11,000,000 786.1M USD – Q2 2013 or earlier 1 quarter
BP BP (ADR) 19.8% 18,597,482 776.3M USD – Q2 2013 or earlier 1 quarter
Theravance Inc 16.2% 16,538,977 637.2M USD – Q2 2013 or earlier 1 quarter
MU Micron Technology 15.1% 41,500,000 594.7M USD – Q2 2013 or earlier 1 quarter
AIG American International Group 11.5% 10,120,227 452.4M USD – Q2 2013 or earlier 1 quarter
Rovi Corp 3.6% 6,160,000 140.7M USD – Q2 2013 or earlier 1 quarter
Idenix Pharmaceuticals Inc 2.5% 26,767,000 96.6M USD – Q2 2013 or earlier 1 quarter
Citigroup Inc 1.9% 94,246,007 74.1M USD – Q2 2013 or earlier 1 quarter
ORCL Oracle Corporation 1.9% 2,386,890 73.3M USD – Q2 2013 or earlier 1 quarter
Chipmos Tech Bermuda Ltd 1.4% 2,763,530 53.5M USD – Q2 2013 or earlier 1 quarter
Novagold Res Inc 1.2% 21,688,300 45.8M USD – Q2 2013 or earlier 1 quarter
Syneron Medical Ltd 0.9% 4,000,000 34.8M USD – Q2 2013 or earlier 1 quarter
Yamana Gold Inc 0.8% 3,255,500 31.0M USD – Q2 2013 or earlier 1 quarter
Alliance One Intl Inc 0.7% 7,669,969 29.1M USD – Q2 2013 or earlier 1 quarter
Central Pac Finl Corp 0.7% 1,491,731 26.9M USD – Q2 2013 or earlier 1 quarter
Ituran Location And Control 0.4% 1,038,342 17.5M USD – Q2 2013 or earlier 1 quarter
Enzon Pharmaceuticals Inc 0.4% 7,691,453 15.4M USD – Q2 2013 or earlier 1 quarter
American Intl Group Inc 0.3% 656,443 12.0M USD – Q2 2013 or earlier 1 quarter
Kinross Gold Corp 0.3% 2,102,700 10.7M USD – Q2 2013 or earlier 1 quarter
Aveo Pharmaceuticals Inc 0.2% 3,829,350 9.6M USD – Q2 2013 or earlier 1 quarter
Novacopper Inc 0.2% 5,005,298 8.8M USD – Q2 2013 or earlier 1 quarter
Pretium Res Inc < 0.1% 155,700 1.0M USD – Q2 2013 or earlier 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 94.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Inc principal 51.0M USD 79.4M USD
  • Micron Technology Inc principal 11.4M USD 15.2M USD

Breakdown by sector

  • Energy 19.8%
  • Technology 17.0%
  • Financials 11.5%
  • not in our coverage 51.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close